Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LDHA | P00338 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL9950136 | 1.00 | — | — | |
| Bicarbonate SCHEMBL2028638 | 0.95 | CA4 (0.42) | CA4CA1FAHD1CA2CA9 | |
| Bicarbonate SCHEMBL472827 | 0.95 | — | — | |
| Bicarbonate SCHEMBL16225125 | 0.91 | CA4 (0.43) | CA4CA1FAHD1CA2CA9 | |
| Bicarbonate SCHEMBL2454268 | 0.90 | — | — | |
| Bicarbonate SCHEMBL570557 | 0.90 | — | — | |
| Bicarbonate SCHEMBL873152 | 0.90 | CA4 (0.39) | CA4CA1FAHD1CA2CA9 | |
| Bicarbonate SCHEMBL21734207 | 0.90 | — | — | |
| Bicarbonate SCHEMBL21638664 | 0.90 | CA4 (0.39) | CA4CA1FAHD1CA2CA9 | |
| Bicarbonate SCHEMBL28853718 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112262128-A | Method for forming aryl carbon-nitrogen bond by illumination and photoreactor for carrying out the reaction | 科罗拉多州立大学研究基金会 | 2021-01-22 | — | — | CN | claimed |
| US-20200147581-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2020-05-14 | — | — | US | claimed |
| US-20190345122-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2019-11-14 | — | — | US | claimed |
| US-20170271637-A1 | METHOD OF MANUFACTURING POROUS POLYMER MEMBRANE USING WATER PRESSURE AND BATTERY SEPARATOR COMPRISING POROUS POLYMER MEMBRANE MANUFACTURED BY THE METHOD | SANGMYUNG UNIVERSITY SEOUL INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2017-09-21 | — | — | US | claimed |
| WO-2007140525-A1 | A METHOD OF TREATMENT AND PROPHYLAXIS OF EVENTS, CONDITIONS AND DISEASES OF THE SYSTEMIC VASCULATURE AN IMMUNE FUNCTION TO DECREASE CARDIOVASCULAR RISK AND PATHOGENIC INFECTION | HOENIG MICHEL (AU) | 2007-12-13 | — | — | WO | claimed |
| US-20250257315-A1 | CARBO-IONIC CULTURES AND EXTRACTS AND APPLICATIONS THEREOF | Bio Capital Holdings, LLC | 2025-08-14 | — | — | US | disclosed |
| US-12270023-B2 | Carbo-ionic cultures and extracts and applications thereof | Bio Capital Holdings, LLC (US) | 2025-04-08 | — | — | US | disclosed |
| US-RE50296-E1 | Electron beam resist composition | THE UNIVERSITY OF MANCHESTER (GB) | 2025-02-11 | — | — | US | disclosed |
| US-20220169607-A1 | CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2022-06-02 | — | — | US | disclosed |
| US-20220145240-A1 | CARBO-IONIC CULTURES AND EXTRACTS AND APPLICATIONS THEREOF | BIOCAPITAL HOLDINGS, LLC | 2022-05-12 | — | — | US | disclosed |
| US-11316146-B2 | Redox and ion-adsorption electrodes and energy storage devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-26 | — | — | US | disclosed |
| CN-113376958-A | Electron beam resist composition | 曼彻斯特大学 | 2021-09-10 | — | — | CN | disclosed |
| US-20080137316-A1 | CONDUCTIVE PATTERNS AND METHODS OF USING THEM | CITIBANK, N.A. | 2008-06-12 | — | — | US | disclosed |
| WO-2008036752-A2 | SOLVENT SYSTEMS FOR METALS AND INKS | FRY'S METALS, INC. (US) | 2008-03-27 | — | — | WO | disclosed |
| WO-2008017062-A1 | PARTICLES AND INKS AND FILMS USING THEM | FRY'S METALS, INC. (US) | 2008-02-07 | — | — | WO | disclosed |
| US-20080032047-A1 | PARTICLES AND INKS AND FILMS USING THEM | CITIBANK, N.A. | 2008-02-07 | — | — | US | disclosed |
| WO-2007140525-A1 | A METHOD OF TREATMENT AND PROPHYLAXIS OF EVENTS, CONDITIONS AND DISEASES OF THE SYSTEMIC VASCULATURE AN IMMUNE FUNCTION TO DECREASE CARDIOVASCULAR RISK AND PATHOGENIC INFECTION | HOENIG MICHEL (AU) | 2007-12-13 | — | — | WO | disclosed |
| US-6693154-B2 | AN ORGANOMETALLIC COMPLEX CONTAINS A TRANSITION OR LANTHANIDE METAL AND 1,3-BIS(ARYLIMINO)ISOINDOLINE OR 1,3-BIS(HETEROARYLIMINO) ISOINDOLINE; ETHYLENE COPOLYMER WITH HIGH MOLECULAR WEIGHT, BROAD MOLECULAR WEIGHT DISTRIBUTION | EQUISTAR CHEMICALS, LP | 2004-02-17 | — | — | US | disclosed |
| US-20030065113-A1 | Transition metal catalysts for olefin polymerization | EQUISTAR CHEMICALS, LP | 2003-04-03 | — | — | US | disclosed |
| US-6383975-B1 | CATALYTIC HYDROTREATMENT OF MIDDLE AND HEAVY OILS, IMPREGNATION OF GROUP IVB METAL ON ALUMINA, DRYING AND ROASTING IMPREGNATION OF THE ALUMINA WITH A TI COMPOUND, SOLUBLE IN AN ORGANIC SOLVENT, | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2002-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169607-A1 | CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS | PCNA, PPOX, PARP1 | CA4 1388/4885CA1 3909/4885FAHD1 4227/4885 |
| US-20190345122-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | TYR, CRY2, CRY1 | CA4 205/4885CA1 356/4885FAHD1 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.